PharmApprove Announces Strategic Alliance With NDA Group

“By working together, we are able to help companies get their products to market more efficiently with an optimized global label and market access position,” explained Dr. Laurie Smaldone, President and CSO, PharmApprove. “Too often companies hire one firm for US and another for EU regulatory advice and furthermore delink the planning for regulatory and market access success. This alliance offers a single partner who can provide global solutions instead of reinventing the wheel for every new market, thus saving time and money.”

Read more here.